Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 60 microgram - injection, suspension - excipient ingredients: octoxinol 9; monobasic sodium phosphate; water for injections; dibasic sodium phosphate; sodium chloride - fluzone high-dose quadrivalent (qiv) is indicated for active immunisation for the prevention of influenza disease. fluzone high-dose quadrivalent is indicated for use in persons 60 years of age and older., the use of fluzone high-dose quadrivalent (qiv) should be based on official recommendations., see section 5.1 clinical trials for information on the effects on influenza associated complications.

Australia - English - Department of Health (Therapeutic Goods Administration)

gro clinics (online) pty ltd - zinc citrate dihydrate, quantity: 23.36 mg (equivalent: zinc, qty 7.5 mg); thiamine nitrate, quantity: 6.17 mg (equivalent: thiamine, qty 5 mg); riboflavin, quantity: 5 mg; nicotinamide, quantity: 5 mg; biotin, quantity: 1 mg; cyanocobalamin, quantity: 100 microgram; ascorbic acid, quantity: 50 mg; d-alpha-tocopheryl acid succinate, quantity: 8.26 mg (equivalent: d-alpha-tocopherol, qty 6.71 mg); folic acid, quantity: 200 microgram; serenoa repens, quantity: 53.33 mg (equivalent: serenoa repens, qty 160 mg) - capsule, hard - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; mannitol; maltodextrin; crospovidone; maize starch; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides - maintain/support hair growth ; maintain/support hair health ; maintain/support scalp health

Australia - English - Department of Health (Therapeutic Goods Administration)

zip diagnostics pty ltd - ct701 - infectious disease ivds - the zip-covx-p2 test is performed using the zip-p2 instrument. the test and instrument function together as a complete in vitro point-of-care diagnostic system. the test provides qualitative detection of sars-cov-2 rna using isothermal nucleic acid amplification technology. the function of the zip-covx-p2 test is to aid diagnosis of covid-19 in symptomatic individuals or to screen for sars-cov-2 infection in asymptomatic individuals. the test is intended for use by healthcare professionals in dedicated test spaces (e.g. hospital emergency, intensive care, general practice, antiviral treatment clinics, or other sites established for screening and testing purposes). the test can also be used by laboratory-trained professionals in pathology settings. minimal training is required as the test is menu-driven with a screen-prompted automated workflow that includes result interpretation and reporting. a synthetic flocked swab is used to obtain an oropharyngeal (throat) and bilateral mid-turbinate (nasal) sample. dry swab samples must be used because swabs in liquid transport media may interfere with test performance.

Australia - English - Department of Health (Therapeutic Goods Administration)

gro clinics (online) pty ltd - zinc citrate dihydrate, quantity: 46.73 mg (equivalent: zinc, qty 15 mg); thiamine nitrate, quantity: 12.34 mg (equivalent: thiamine, qty 10 mg); riboflavin, quantity: 10 mg; nicotinamide, quantity: 10 mg; biotin, quantity: 2 mg; cyanocobalamin, quantity: 200 microgram; ascorbic acid, quantity: 100 mg; d-alpha-tocopheryl acid succinate, quantity: 16.52 mg (equivalent: d-alpha-tocopherol, qty 13.4 mg); folic acid, quantity: 400 microgram; serenoa repens, quantity: 106.67 mg (equivalent: serenoa repens, qty 320 mg); potassium iodide, quantity: 65.4 microgram (equivalent: iodine, qty 50 microgram); colloidal anhydrous silica, quantity: 21.44 mg (equivalent: silicon, qty 10 mg); equisetum arvense, quantity: 45.45 mg (equivalent: equisetum arvense, qty 250 mg); bacopa monnieri, quantity: 12.5 mg (equivalent: bacopa monnieri, qty 250 mg); colecalciferol, quantity: 0.025 mg - capsule, hard - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; magnesium stearate; hypromellose; mannitol; maltodextrin; crospovidone; calcium carbonate; purified water; silicon dioxide; calcium sulfate; maize starch; acacia; dl-alpha-tocopherol; sucrose; medium chain triglycerides - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; maintain/support hair growth ; maintain/support hair health ; maintain/support hair strength/thickness ; aid/assist nail growth ; maintain/support nail health/strength/thickness ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support healthy body tissues ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; maintain/support general mental wellbeing ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support healthy reproductive hormones ; maintain/support testosterone level ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support skin regeneration ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

scoliosis clinics australia pty ltd - 41439 - orthosis, spinal, - spinal support and correctional orthosis

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - simvastatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - simvastatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - simvastatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

ipsen pty ltd - clostridium botulinum type a toxin - haemagglutinin complex -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant -